Autocrine and paracrine actions of GnRH through the GnRH-R in nervous system tumors have been observed in meningiomas and low-grade glioblastoma multiforme, and it has been proposed that GnRH-R could be used as a prognosis marker [143,144]. This evidence concerns the gene GNRHR and glioblastoma.